LOGO
LOGO

Clinical Trial Calendar

Results Date
Company Name
Ticker
Event
Indication
Outcome
Mid 2026
Rocket Pharmaceuticals, Inc.
RCKT
Data readout from Phase 2 study of RP-A501
Danon disease
Mid 2026
Aura Biosciences, Inc.
AURA
Initial three-month data from Phase 1b/2 Trial of Bel-sar
Non-Muscle-Invasive Bladder Cancer
Mid 2026
Atea Pharmaceuticals, Inc.
AVIR
Topline results from Phase 3 trial of bemnifosbuvir in combination with ruzasvir (C-BEYOND)
Hepatitis C Virus (HCV) treatment-Naïve Patients in US and Canada
Mid 2026
Benitec Biopharma
BNTC
Interim results from Cohort 2 of Phase 1b/2a trial of BB-301
Oculopharyngeal Muscular Dystrophy-related Dysphagia
Mid 2026
Coherus Oncology, Inc.
CHRS
First data readout from Phase 2 randomized trial of casdozokitug/toripalimab/bevacizumab
1st-line hepatocellular carcinoma (HCC).
Mid 2026
Karyopharm Therapeutics Inc.
KPTI
Top-line data from Phase 3 trial of selinexor (XPORT-EC-042)
TP53 wild-type endometrial cancer
Mid 2026
CervoMed Inc.
CRVO
Initial biomarker data from Phase 2a study of Neflamapimod
non-fluent variant primary progressive aphasia (nfvPPA)
Mid 2026
ACADIA Pharmaceuticals Inc
ACAD
Topline results from Phase 2 study of ACP-204 (RADIANT)
Alzheimer’s disease psychosis
Mid 2026
EyePoint Pharmaceuticals, Inc.
EYPT
Topline data from phase III trial of DURAVYU (LUCIA )
Wet age-related macular degeneration
Mid 2026
MetaVia Inc.
MTVA
Interim data readout from Part 3 of Phase 1 trial of DA-1726
Obesity
Mid 2026
Moleculin Biotech Inc
MBRX
Interim data from Phase 3 trial of Annamycin in combination with cytarabine (MIRACLE)
Relapsed or refractory acute myeloid leukemia
Mid 2026
ArriVent Biopharma, Inc.
AVBP
Topline data from Phase 3 trial of Firmonertinib (FURVENT )
Non-small cell lung cancer (NSCLC) patients whose tumors contain EGFR exon 20 insertion mutations
Mid 2026
Kezar Life Sciences, Inc.
KZR
Topline Phase 2b data of zetomipzomib (PALIZADE)
Active lupus nephritis
Mid 2026
Avalo Therapeutics, Inc.
AVTX
Topline data from Phase 2 trial of AVTX-009 (LOTUS)
Hidradenitis suppurativa
Mid 2026
Repare Therapeutics Inc.
RPTX
Final readout of proof-of-concept from Phase 1 trial of RP-1664 in adult and adolescent (LIONS)
TRIM37-high solid tumors
Mid 2026
Pliant Therapeutics, Inc.
PLRX
Data from Phase 2b trial of bexotegrast (BEACON-IPF)
Idiopathic pulmonary fibrosis (IPF).
Phase 2b trial of bexotegrast in patients with idiopathic pulmonary fibrosis discontinued following recommendations from an independent Data Safety Monitoring Board. The company announced the decision on Mar. 3, 2025.
Mid 2026
Context Therapeutics Inc.
CNTX
Initial data from Phase 1 trial of CT-95
MSLN-expressing advanced solid tumors, including ovarian, pancreatic, lung, and mesothelioma cancers
Mid 2026
Alto Neuroscience, Inc.
ANRO
Topline data from Phase 2b trial of ALTO-300
Major depressive disorder
Mid 2026
Annovis Bio, Inc.
ANVS
Symptomatic data from Phase 3 study of buntanetap
Alzheimer's disease
Mid 2026
MediWound Ltd.
MDWD
Interim analysis from Phase III trial of EscharEx (VALUE)
Venous leg ulcers
Mid 2026
Sionna Therapeutics, Inc.
SION
Topline data from Phase 2a Proof-of-Concept trial of NBD1 stabilizer in combination with standard of care
Cystic fibrosis
Mid 2026
Sionna Therapeutics, Inc.
SION
Topline data from Phase 2a MAD trial of NBD1 stabilizer with complementary modulator in healthy volunteers
Cystic fibrosis
29-May-2026 To 02-Jun-2026
Aktis Oncology, Inc.
AKTS
Clinical imaging and dosimetry data of AKY-2519
Metastatic castration-resistant prostate cancer (mCRPC) and various solid tumors
29-May-2026 To 02-Jun-2026
Zentalis Pharmaceuticals, LLC
ZNTL
Data from Part 1 of Phase 1b trial of Azenosertib in combiantion with Paclitaxel (MUIR)
Platinum-Resistant Ovarian Cancer
29-May-2026 To 02-Jun-2026
Compass Therapeutics, Inc
CMPX
Data from Phase 1 trial of CTX-8371
Advanced malignancies treated in the post-checkpoint inhibitor setting
Buy this Content
Editors Pick
dollartree 28052026 lt

Dollar Tree Stock Up 13% On Q1 Results, Positive Outlook, Deal With DoorDash

May 28, 2026 08:13 ET
dicksportinggoods 27052026 lt

DICK'S Sporting Cuts FY26 Earnings View, Backs Adj. EPS, Sales Forecast After Q1 Growth; Stock Down

May 27, 2026 09:46 ET
airfranceairbus 22052026 lt

French Court Rules Air France And Airbus Guilty In 2009 Plane Crash; Companies To Appeal

May 22, 2026 05:33 ET
walmart 21052026 lt

Walmart Sees Growth In Q2, Backs FY27 Outlook After Strong Q1; Stock Down

May 21, 2026 08:33 ET
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap